102 related articles for article (PubMed ID: 11721410)
1. [Dynamic changes and localization of plasma heparin cofactor II before and after delivery in hypertensive pregnancy].
Chen X; Zhang G; Wang C
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):468-70. PubMed ID: 11721410
[TBL] [Abstract][Full Text] [Related]
2. [Heparin cofactor II (HCII) activity and antigen assay and their significance in thrombotic diseases].
Dai CW; Zhang GS
Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):452-4. PubMed ID: 14575585
[TBL] [Abstract][Full Text] [Related]
3. [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role].
Rossi EB; Duboscq CL; Kordich LC
Medicina (B Aires); 1999; 59(1):95-104. PubMed ID: 10349131
[TBL] [Abstract][Full Text] [Related]
4. Heparin cofactor II: a new marker for pre-eclampsia.
Bellart J; Gilabert R; Cabero L; Fontcuberta J; Monasterio J; Miralles RM
Blood Coagul Fibrinolysis; 1998 Mar; 9(2):205-8. PubMed ID: 9622221
[TBL] [Abstract][Full Text] [Related]
5. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.
Toulon P; Vitoux JF; Fiessinger JN; Sicard D; Aiach M
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):435-9. PubMed ID: 1718466
[TBL] [Abstract][Full Text] [Related]
6. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
Mackie IJ; Segal H; Burren T; Gallimore M; Walshe KJ; Robinson G; Machin SJ
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):647-51. PubMed ID: 2133244
[TBL] [Abstract][Full Text] [Related]
7. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
Tanaka KA; Szlam F; Vinten-Johansen J; Cardin AD; Levy JH
Thromb Haemost; 2005 Oct; 94(4):808-13. PubMed ID: 16270635
[TBL] [Abstract][Full Text] [Related]
8. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
[TBL] [Abstract][Full Text] [Related]
9. Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II.
Giri TK; Tollefsen DM
Blood; 2006 Apr; 107(7):2753-8. PubMed ID: 16339402
[TBL] [Abstract][Full Text] [Related]
10. Heparin cofactor II deficiency in patients infected with the human immunodeficiency virus.
Toulon P; Lamine M; Ledjev I; Guez T; Holleman ME; Sereni D; Sicard D
Thromb Haemost; 1993 Nov; 70(5):730-5. PubMed ID: 8128426
[TBL] [Abstract][Full Text] [Related]
11. Heparin cofactor II modulates the response to vascular injury.
Tollefsen DM
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):454-60. PubMed ID: 17194895
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji).
Kondo S; Tokunaga F; Kario K; Matsuo T; Koide T
Blood; 1996 Feb; 87(3):1006-12. PubMed ID: 8562924
[TBL] [Abstract][Full Text] [Related]
13. [The vitronectin anchors on placenta tissue of hypertensive pregnancy].
Chen XQ; Zhang GS
Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):463-6. PubMed ID: 12212119
[TBL] [Abstract][Full Text] [Related]
14. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex.
Maekawa H; Sato H; Tollefsen DM
Thromb Res; 2000 Dec; 100(5):443-51. PubMed ID: 11150588
[TBL] [Abstract][Full Text] [Related]
15. High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention.
Takamori N; Azuma H; Kato M; Hashizume S; Aihara K; Akaike M; Tamura K; Matsumoto T
Circulation; 2004 Feb; 109(4):481-6. PubMed ID: 14744972
[TBL] [Abstract][Full Text] [Related]
16. Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.
Sutherland JS; Bhakta V; Sheffield WP
Thromb Res; 2006; 117(4):447-61. PubMed ID: 15869786
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
Halldórsdóttir AM; Zhang L; Tollefsen DM
Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-inhibitor complexes in the blood during and after delivery.
Andersson T; Lorentzen B; Hogdahl H; Clausen T; Mowinckel MC; Abildgaard U
Thromb Res; 1996 Apr; 82(2):109-17. PubMed ID: 9163064
[TBL] [Abstract][Full Text] [Related]
19. Further studies on the mechanism for the antithrombotic effects of naroparcil, an orally active thiozyloside compound.
Masson P; Theveniaux J; Coup D; Grégoire T; Vaillot M; Dupouy D; Sié P; Boneu B; Millet J
Thromb Haemost; 1999 Jun; 81(6):945-50. PubMed ID: 10404773
[TBL] [Abstract][Full Text] [Related]
20. Plasma total and ultrafiltrable calcium in normal pregnancy, hypertension in pregnancy and pre-eclampsia.
Oladipo OO; Afolabi BB; Okorodudu AO
Niger Postgrad Med J; 2007 Sep; 14(3):213-6. PubMed ID: 17767205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
